David Turkaly
Stock Analyst at JMP Securities
(2.32)
# 2,544
Out of 4,862 analysts
141
Total ratings
43.41%
Success rate
-2.98%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $11.01 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $58.90 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $70.09 | +42.67% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $241.34 | +16.02% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $12.17 | +105.42% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $31.90 | +72.41% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $91.28 | +36.94% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $480.62 | +4.03% | 1 | May 5, 2025 | |
| SYK Stryker | Reiterates: Market Perform | n/a | $377.30 | - | 3 | May 5, 2025 | |
| TFX Teleflex | Reiterates: Market Perform | n/a | $119.93 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.73 | +304.62% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $50 | $21.11 | +136.85% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $9.75 | +166.67% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $17.42 | +83.70% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $7.94 | +101.51% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $112 | $77.83 | +43.90% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $1.82 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.80 | -21.05% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $3.68 | +8.70% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.96 | -44.20% | 1 | Oct 6, 2017 |
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.01
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $58.90
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $70.09
Upside: +42.67%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $241.34
Upside: +16.02%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $12.17
Upside: +105.42%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $31.90
Upside: +72.41%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $91.28
Upside: +36.94%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $480.62
Upside: +4.03%
Stryker
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $377.30
Upside: -
Teleflex
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $119.93
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.73
Upside: +304.62%
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $21.11
Upside: +136.85%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $9.75
Upside: +166.67%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $17.42
Upside: +83.70%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $7.94
Upside: +101.51%
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $77.83
Upside: +43.90%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $1.82
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.80
Upside: -21.05%
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $3.68
Upside: +8.70%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.96
Upside: -44.20%